● Recruiting

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Condition: Ovarian Cancer · Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

PhasePhase 3

Planned participants420

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a randomized, Phase 3 trial designed to evaluate the efficacy and safety of azenosertib compared to Investigator's choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expression.

This description comes directly from the study's public registry record.

Talk to the study team

Project Director · 858.263.4333 · medicalaffairs@zentalis.com

Always discuss trial participation with your own doctor first.

Locations (58)

Site 0107	Phoenix, Arizona, United States	Not Yet Recruiting
Site 0110	Antioch, California, United States	Not Yet Recruiting
Site 0115	San Francisco, California, United States	Not Yet Recruiting
Site 0101	Torrance, California, United States	Recruiting
Site 0111	Camden, New Jersey, United States	Not Yet Recruiting
Site 0108	Columbus, Ohio, United States	Not Yet Recruiting
Site 0105	Portland, Oregon, United States	Not Yet Recruiting
Site 0109	Philadelphia, Pennsylvania, United States	Not Yet Recruiting
Site 0113	Philadelphia, Pennsylvania, United States	Not Yet Recruiting
Site 0114	Willow Grove, Pennsylvania, United States	Not Yet Recruiting
Site 0112	Sioux Falls, South Dakota, United States	Not Yet Recruiting
Site 1101	Randwick, New South Wales, Australia	Not Yet Recruiting

+ 46 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07546500